Application Nr Approved Date Route Status External Links
ANDA212411 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Posaconazole Delayed-Release Tablets Is An Azole Antifungal Agent Indicated For: Prophylaxis Of Invasive Aspergillus And Candida Infections In Patients Who Are At High Risk Of Developing These Infections Due To Being Severely Immunocompromised, Such As Hsct Recipients With Gvhd Or Those With Hematologic Malignancies With Prolonged Neutropenia From Chemotherapy. (1.1) 1.1 Prophylaxis Of Invasive Aspergillus And Candida Infections Posaconazole Delayed-Release Tablets Are Indicated For Prophylaxis Of Invasive Aspergillus And Candida Infections In Patients Who Are At High Risk Of Developing These Infections Due To Being Severely Immunocompromised, Such As Hematopoietic Stem Cell Transplant (Hsct) Recipients With Graft-Versus-Host Disease (Gvhd) Or Those With Hematologic Malignancies With Prolonged Neutropenia From Chemotherapy. Posaconazole Delayed-Release Tablets 100 Mg Are Indicated In Patients 13 Years Of Age And Older.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Posaconazole POSACONAZOLE ZINC3938482

Comments